208 related articles for article (PubMed ID: 15041461)
1. Fluorescence microscopy studies with a fluorescent glibenclamide derivative, a high-affinity blocker of pancreatic beta-cell ATP-sensitive K+ currents.
Zünkler BJ; Wos-Maganga M; Panten U
Biochem Pharmacol; 2004 Apr; 67(8):1437-44. PubMed ID: 15041461
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ATP-sensitive K+ channels by taurine through a benzamido-binding site on sulfonylurea receptor 1.
Park EJ; Bae JH; Kim SY; Lim JG; Baek WK; Kwon TK; Suh SI; Park JW; Lee IK; Ashcroft FM; Song DK
Biochem Pharmacol; 2004 Mar; 67(6):1089-96. PubMed ID: 15006545
[TBL] [Abstract][Full Text] [Related]
3. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
[TBL] [Abstract][Full Text] [Related]
4. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
Gribble FM; Tucker SJ; Seino S; Ashcroft FM
Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
[TBL] [Abstract][Full Text] [Related]
6. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
Flechtner I; de Lonlay P; Polak M
Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
[TBL] [Abstract][Full Text] [Related]
7. Kir6.2-dependent high-affinity repaglinide binding to beta-cell K(ATP) channels.
Hansen AM; Hansen JB; Carr RD; Ashcroft FM; Wahl P
Br J Pharmacol; 2005 Feb; 144(4):551-7. PubMed ID: 15678092
[TBL] [Abstract][Full Text] [Related]
8. Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels.
Song DK; Ashcroft FM
Br J Pharmacol; 2001 May; 133(1):193-9. PubMed ID: 11325810
[TBL] [Abstract][Full Text] [Related]
9. Unresponsiveness to glibenclamide during chronic treatment induced by reduction of ATP-sensitive K+ channel activity.
Kawaki J; Nagashima K; Tanaka J; Miki T; Miyazaki M; Gonoi T; Mitsuhashi N; Nakajima N; Iwanaga T; Yano H; Seino S
Diabetes; 1999 Oct; 48(10):2001-6. PubMed ID: 10512365
[TBL] [Abstract][Full Text] [Related]
10. KATP-channels in beta-cells in tissue slices are directly modulated by millimolar ATP.
Speier S; Yang SB; Sroka K; Rose T; Rupnik M
Mol Cell Endocrinol; 2005 Jan; 230(1-2):51-8. PubMed ID: 15664451
[TBL] [Abstract][Full Text] [Related]
11. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).
Hambrock A; de Oliveira Franz CB; Hiller S; Osswald H
J Pharmacol Exp Ther; 2006 Mar; 316(3):1031-7. PubMed ID: 16306272
[TBL] [Abstract][Full Text] [Related]
12. Functional modulation of the ATP-sensitive potassium channel by extracellular signal-regulated kinase-mediated phosphorylation.
Lin YF; Chai Y
Neuroscience; 2008 Mar; 152(2):371-80. PubMed ID: 18280666
[TBL] [Abstract][Full Text] [Related]
13. Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
Tomoda T; Yunoki T; Naito S; Ito Y; Teramoto N
Eur J Pharmacol; 2005 Nov; 524(1-3):1-10. PubMed ID: 16242124
[TBL] [Abstract][Full Text] [Related]
14. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
Guillemare E; Honore E; De Weille J; Fosset M; Lazdunski M; Meisheri K
Mol Pharmacol; 1994 Jul; 46(1):139-45. PubMed ID: 8058048
[TBL] [Abstract][Full Text] [Related]
15. Kir6.1 is the principal pore-forming subunit of astrocyte but not neuronal plasma membrane K-ATP channels.
Thomzig A; Wenzel M; Karschin C; Eaton MJ; Skatchkov SN; Karschin A; Veh RW
Mol Cell Neurosci; 2001 Dec; 18(6):671-90. PubMed ID: 11749042
[TBL] [Abstract][Full Text] [Related]
16. Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic beta-cells.
Mukai E; Ishida H; Kato S; Tsuura Y; Fujimoto S; Ishida-Takahashi A; Horie M; Tsuda K; Seino Y
Am J Physiol; 1998 Jan; 274(1):E38-44. PubMed ID: 9458745
[TBL] [Abstract][Full Text] [Related]
17. Molecular structure of the glibenclamide binding site of the beta-cell K(ATP) channel.
Mikhailov MV; Mikhailova EA; Ashcroft SJ
FEBS Lett; 2001 Jun; 499(1-2):154-60. PubMed ID: 11418131
[TBL] [Abstract][Full Text] [Related]
18. Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells.
Lawrence CL; Proks P; Rodrigo GC; Jones P; Hayabuchi Y; Standen NB; Ashcroft FM
Diabetologia; 2001 Aug; 44(8):1019-25. PubMed ID: 11484080
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory modulation of ATP-sensitive potassium channels by gallate-ester moiety of (-)-epigallocatechin-3-gallate.
Baek WK; Jang BC; Lim JH; Kwon TK; Lee HY; Cho CH; Kim DK; Shin DH; Park JG; Lim JG; Bae JH; Bae JH; Yoo SK; Park WK; Song DK
Biochem Pharmacol; 2005 Nov; 70(11):1560-7. PubMed ID: 16216226
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
Stephan D; Winkler M; Kühner P; Russ U; Quast U
Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]